For Patients

Diabetes

An estimated 30.3 million (23.1 million diagnosed and 7.2 million undiagnosed) people in the U.S. — approximately 9.4% of the population — have diabetes. An estimated 84.1million people in the U.S. (1 out of 3 adults or 33.9%) have prediabetes and 9 out of 10 people in the U.S. do not know they have prediabetes.With the incidence of diabetes skyrocketing, it is important that the FDA do what we can to inform patients and the health professionals. FDA is committed to getting accurate, science-based information in the hands of people with diabetes and the people who provide medical care - so they can recommend and use foods, medicines, and devices to maintain and improve patient health.What’s new in Diabetes? 

CELP - The Cardiovascular
and Endocrine Liaison Program


Learn more about the Office of Health and Constituent Affairs - CELP program.

FDA recently made updates to part of their email based communication. You can still view the updates by going to Internet Archive Wayback Machine for FDA.gov. The ForPatients section of FDA.GOV was backed up last on July 29, 2017. This non-profit Internet Archive has archived some (but not all) of FDA.gov pages and files since 1996.

 

2017 Updates
  • 07/19/2017 Novo Nordisk Recalls Cartridge Holders In Certain Novopen Echo® Insulin Delivery Devices Due to Potential Health Risks

  • 07/05/2017 Company Safety Alert: Novo Nordisk Recalls Cartridge Holders In Certain Novopen Echo® Insulin Delivery Devices Due to Potential Health Risks

  • 05/16/2017  FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)

  • 05/02/2017 FDA Extends Menu Labeling Compliance Date to 2018

  • 01/12/2017 Safety Communication:  Safety Concerns with Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment

 

Past Meetings
  • FDA-Patient Dialogue on Unmet Needs in Diabetes Meeting was held on Monday, November 3, 2014. FDA hosted a discussion with Type 1 and Type 2 diabetes communities to provide FDA with real-world perspectives as the agency deliberates complex policies that affect the safety and effectiveness of marketed products on which people with diabetes depend.

  • Diabetes Live Chat. On March 31, 2014, discussion was held on the FDA’s new proposed guidelines and what standards blood glucose meters should have to meet before the FDA clears them for sale. View our recent LiveChat with Bennett Dunlap creator of StripSafety.com and FDA's Courtney Lias Ph.D, Director of Chemistry and Toxicology Devices. 

Past Podcast/Webinar's      

 

Subscribe to FDA Diabetes Monitor
E-mail updates on safety and regulatory issues related to diabetes, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.

 

Page Last Updated: 09/11/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English